Cargando…
Toll-like receptor 4 and its associated proteins as prognostic factors for HCC treated by post-radiotherapy surgery
Locally advanced hepatocellular carcinoma (HCC) treated by radiotherapy (RT) may be suited for further treatment with surgery. As a critical mediator of the post-RT immune response, Toll-like receptor 4 (TLR4) and its associated proteins may serve as prognostic factors for patients with HCC treated...
Autores principales: | Wu, Zhi-Feng, Wang, Ying, Yang, Ping, Hou, Jia-Zhou, Zhang, Jian-Ying, Hu, Yong, Zeng, Zhao-Chong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6004720/ https://www.ncbi.nlm.nih.gov/pubmed/29928336 http://dx.doi.org/10.3892/ol.2018.8583 |
Ejemplares similares
-
The Degree of Lipiodol Accumulation Can Be an Indicator of Successful Treatment for Unresectable Hepatocellular Carcinoma (HCC) Patients - in the Case of Transcatheter Arterial Chemoembolization (TACE) and External Beam Radiotherapy (EBRT)
por: Yang, Ping, et al.
Publicado: (2016) -
Activation of the Toll-like receptor 2 signaling pathway inhibits the proliferation of HCC cells in vitro
por: Chen, Yi, et al.
Publicado: (2019) -
Radiotherapy treatment of adrenal gland metastases from hepatocellular carcinoma: clinical features and prognostic factors
por: Zhou, Le-Yuan, et al.
Publicado: (2014) -
Predictive and Prognostic Factors in HCC Patients Treated with Sorafenib
por: Brunetti, Oronzo, et al.
Publicado: (2019) -
Toll-Like Receptors and the Response to Radiotherapy in Solid Tumors: Challenges and Opportunities
por: Haroun, Ryma, et al.
Publicado: (2023)